The coil transcatheter embolization and occlusion devices market size has grown strongly in recent years. It will grow from $1.76 billion in 2025 to $1.9 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing prevalence of vascular disorders, expansion of interventional radiology practices, widespread use of platinum-based embolization coils, growth in hospital catheterization labs, rising clinician expertise in endovascular procedures.
The coil transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing adoption of image-guided embolization techniques, rising demand for next-generation coil technologies, expansion of tumor embolization procedures, growing focus on minimally invasive treatments, continuous innovation in embolic materials. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising use of detachable and precision coils, growing demand for neurovascular interventions, expansion of advanced coil materials and designs, enhanced focus on procedural safety and accuracy.
The growing emphasis on personalized medicine is expected to drive the expansion of the coil transcatheter embolization and occlusion devices market. Personalized medicine tailors healthcare decisions and treatments based on an individual’s genetic makeup, lifestyle, and environment. The rise in personalized medicine is largely due to advancements in genomic sequencing, which have made it more affordable and accessible to customize treatments according to genetic profiles. Coil transcatheter embolization and occlusion devices contribute to the advancement of personalized medicine by enabling precise, patient-specific treatments. Using advanced imaging, these devices are adapted to an individual’s vascular anatomy, allowing for targeted treatment of abnormal blood vessels or tumors while minimizing damage to healthy tissue. For instance, in February 2024, the Personalized Medicine Coalition, a U.S-based advocacy group for tailored medical treatments, said the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. As a result, the growing emphasis on personalized medicine is fueling the market for coil transcatheter embolization and occlusion devices.
Major companies operating in the coil transcatheter embolization and occlusion devices market are focusing on developing innovative solutions such as hydrogel-core detachable coils to increase packing density, enhance long-term occlusion durability, and reduce the need for multiple coils during embolization. A hydrogel-core coil integrates an expandable hydrogel material within a platinum coil structure, allowing it to expand upon contact with blood and occupy more space within an aneurysm or vessel compared with traditional platinum-only coils. This design provides more stable mechanical occlusion, less dependence on thrombus formation, and improved long-term treatment outcomes. For example, in December 2023, Terumo Medical Corporation, a U.S.-based medical device subsidiary of Terumo Corporation, launched the AZUR HydroPack Peripheral Coil System for high-efficiency packing in peripheral embolization procedures. The system features a 0.018″ primary wind, soft universal-shaped coils ranging from 5 cm to 60 cm, and a proprietary hydrogel that expands to create durable occlusion and promote tissue ingrowth, while offering improved microcatheter stability, smooth deliverability, and reduced procedural time by lowering the number of coils required.
In January 2025, Kaneka Corporation, a Japan-based chemical manufacturer, acquired EndoStream Medical Ltd., a company specializing in coil transcatheter embolization and occlusion devices for brain aneurysm treatment. This acquisition strengthens Kaneka's neurovascular portfolio, particularly by integrating EndoStream's innovative technologies, such as the Nautilus device for wide-neck cerebral aneurysms. Kaneka aims to use this acquisition to accelerate the development and global distribution of advanced coil embolization solutions.
Major companies operating in the coil transcatheter embolization and occlusion devices market are Johnson and Johnson, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Medical Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Balt Extrusion SAS, Phenox GmbH, Acandis GmbH & Co. KG, B. Braun Interventional Systems Inc., EndoShape Inc., Shape Memory Medical Inc., Artio Medical Inc., Kaneka Corporation, Asahi Intecc Co. Ltd., Medico's Hirata Inc., Wallaby Medical, Rapid Medical, Stereotaxis Inc., Imperative Care.
North America was the largest region in the coil transcatheter embolization and occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coil transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coil transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the coil transcatheter embolization and occlusion devices market by increasing costs of imported platinum alloys, nitinol materials, microcatheters, and precision manufacturing equipment. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value components, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing device pricing and affecting procedure costs. However, they are also supporting localized manufacturing, regional supply chain development, and innovation in alternative embolic materials.
The coil transcatheter embolization and occlusion devices market research report is one of a series of new reports that provides coil transcatheter embolization and occlusion devices market statistics, including coil transcatheter embolization and occlusion devices industry global market size, regional shares, competitors with a coil transcatheter embolization and occlusion devices market share, detailed coil transcatheter embolization and occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the coil transcatheter embolization and occlusion devices industry. This coil transcatheter embolization and occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coil transcatheter embolization and occlusion devices are minimally invasive medical devices designed to block (embolize) blood flow in a vessel or abnormal vascular structure. These devices are typically small metal coils that are delivered via a catheter through the vascular system to the target site.
The product types of coil transcatheter embolization and occlusion devices include detachable coils, pushable coils, and others. Detachable coils are implantable devices used in minimally invasive procedures to block blood flow in aneurysms or abnormal blood vessels, allowing for precise placement through a catheter once the target site is confirmed. These devices are applied in various procedures, including hemorrhage control, vascular occlusion, aneurysm treatment, tumor embolization, and others. They are made from materials such as platinum or platinum alloys, nickel titanium (nitinol), stainless steel, and others. Key end users of these devices include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutions.
The coil transcatheter embolization and occlusion devices market consists of sales of hydrogel-coated coils, fibered coils, and neurovascular coils. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The coil transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing adoption of image-guided embolization techniques, rising demand for next-generation coil technologies, expansion of tumor embolization procedures, growing focus on minimally invasive treatments, continuous innovation in embolic materials. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising use of detachable and precision coils, growing demand for neurovascular interventions, expansion of advanced coil materials and designs, enhanced focus on procedural safety and accuracy.
The growing emphasis on personalized medicine is expected to drive the expansion of the coil transcatheter embolization and occlusion devices market. Personalized medicine tailors healthcare decisions and treatments based on an individual’s genetic makeup, lifestyle, and environment. The rise in personalized medicine is largely due to advancements in genomic sequencing, which have made it more affordable and accessible to customize treatments according to genetic profiles. Coil transcatheter embolization and occlusion devices contribute to the advancement of personalized medicine by enabling precise, patient-specific treatments. Using advanced imaging, these devices are adapted to an individual’s vascular anatomy, allowing for targeted treatment of abnormal blood vessels or tumors while minimizing damage to healthy tissue. For instance, in February 2024, the Personalized Medicine Coalition, a U.S-based advocacy group for tailored medical treatments, said the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. As a result, the growing emphasis on personalized medicine is fueling the market for coil transcatheter embolization and occlusion devices.
Major companies operating in the coil transcatheter embolization and occlusion devices market are focusing on developing innovative solutions such as hydrogel-core detachable coils to increase packing density, enhance long-term occlusion durability, and reduce the need for multiple coils during embolization. A hydrogel-core coil integrates an expandable hydrogel material within a platinum coil structure, allowing it to expand upon contact with blood and occupy more space within an aneurysm or vessel compared with traditional platinum-only coils. This design provides more stable mechanical occlusion, less dependence on thrombus formation, and improved long-term treatment outcomes. For example, in December 2023, Terumo Medical Corporation, a U.S.-based medical device subsidiary of Terumo Corporation, launched the AZUR HydroPack Peripheral Coil System for high-efficiency packing in peripheral embolization procedures. The system features a 0.018″ primary wind, soft universal-shaped coils ranging from 5 cm to 60 cm, and a proprietary hydrogel that expands to create durable occlusion and promote tissue ingrowth, while offering improved microcatheter stability, smooth deliverability, and reduced procedural time by lowering the number of coils required.
In January 2025, Kaneka Corporation, a Japan-based chemical manufacturer, acquired EndoStream Medical Ltd., a company specializing in coil transcatheter embolization and occlusion devices for brain aneurysm treatment. This acquisition strengthens Kaneka's neurovascular portfolio, particularly by integrating EndoStream's innovative technologies, such as the Nautilus device for wide-neck cerebral aneurysms. Kaneka aims to use this acquisition to accelerate the development and global distribution of advanced coil embolization solutions.
Major companies operating in the coil transcatheter embolization and occlusion devices market are Johnson and Johnson, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Medical Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Balt Extrusion SAS, Phenox GmbH, Acandis GmbH & Co. KG, B. Braun Interventional Systems Inc., EndoShape Inc., Shape Memory Medical Inc., Artio Medical Inc., Kaneka Corporation, Asahi Intecc Co. Ltd., Medico's Hirata Inc., Wallaby Medical, Rapid Medical, Stereotaxis Inc., Imperative Care.
North America was the largest region in the coil transcatheter embolization and occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coil transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coil transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the coil transcatheter embolization and occlusion devices market by increasing costs of imported platinum alloys, nitinol materials, microcatheters, and precision manufacturing equipment. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value components, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing device pricing and affecting procedure costs. However, they are also supporting localized manufacturing, regional supply chain development, and innovation in alternative embolic materials.
The coil transcatheter embolization and occlusion devices market research report is one of a series of new reports that provides coil transcatheter embolization and occlusion devices market statistics, including coil transcatheter embolization and occlusion devices industry global market size, regional shares, competitors with a coil transcatheter embolization and occlusion devices market share, detailed coil transcatheter embolization and occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the coil transcatheter embolization and occlusion devices industry. This coil transcatheter embolization and occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coil transcatheter embolization and occlusion devices are minimally invasive medical devices designed to block (embolize) blood flow in a vessel or abnormal vascular structure. These devices are typically small metal coils that are delivered via a catheter through the vascular system to the target site.
The product types of coil transcatheter embolization and occlusion devices include detachable coils, pushable coils, and others. Detachable coils are implantable devices used in minimally invasive procedures to block blood flow in aneurysms or abnormal blood vessels, allowing for precise placement through a catheter once the target site is confirmed. These devices are applied in various procedures, including hemorrhage control, vascular occlusion, aneurysm treatment, tumor embolization, and others. They are made from materials such as platinum or platinum alloys, nickel titanium (nitinol), stainless steel, and others. Key end users of these devices include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutions.
The coil transcatheter embolization and occlusion devices market consists of sales of hydrogel-coated coils, fibered coils, and neurovascular coils. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Coil Transcatheter Embolization and Occlusion Devices Market Characteristics
3. Coil Transcatheter Embolization and Occlusion Devices Market Supply Chain Analysis
4. Global Coil Transcatheter Embolization and Occlusion Devices Market Trends and Strategies
5. Coil Transcatheter Embolization and Occlusion Devices Market Analysis of End Use Industries
7. Global Coil Transcatheter Embolization and Occlusion Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Coil Transcatheter Embolization and Occlusion Devices Total Addressable Market (TAM) Analysis for the Market
9. Coil Transcatheter Embolization and Occlusion Devices Market Segmentation
10. Coil Transcatheter Embolization and Occlusion Devices Market Regional and Country Analysis
11. Asia-Pacific Coil Transcatheter Embolization and Occlusion Devices Market
12. China Coil Transcatheter Embolization and Occlusion Devices Market
13. India Coil Transcatheter Embolization and Occlusion Devices Market
14. Japan Coil Transcatheter Embolization and Occlusion Devices Market
15. Australia Coil Transcatheter Embolization and Occlusion Devices Market
16. Indonesia Coil Transcatheter Embolization and Occlusion Devices Market
17. South Korea Coil Transcatheter Embolization and Occlusion Devices Market
18. Taiwan Coil Transcatheter Embolization and Occlusion Devices Market
19. South East Asia Coil Transcatheter Embolization and Occlusion Devices Market
20. Western Europe Coil Transcatheter Embolization and Occlusion Devices Market
21. UK Coil Transcatheter Embolization and Occlusion Devices Market
22. Germany Coil Transcatheter Embolization and Occlusion Devices Market
23. France Coil Transcatheter Embolization and Occlusion Devices Market
24. Italy Coil Transcatheter Embolization and Occlusion Devices Market
25. Spain Coil Transcatheter Embolization and Occlusion Devices Market
26. Eastern Europe Coil Transcatheter Embolization and Occlusion Devices Market
27. Russia Coil Transcatheter Embolization and Occlusion Devices Market
28. North America Coil Transcatheter Embolization and Occlusion Devices Market
29. USA Coil Transcatheter Embolization and Occlusion Devices Market
30. Canada Coil Transcatheter Embolization and Occlusion Devices Market
31. South America Coil Transcatheter Embolization and Occlusion Devices Market
32. Brazil Coil Transcatheter Embolization and Occlusion Devices Market
33. Middle East Coil Transcatheter Embolization and Occlusion Devices Market
34. Africa Coil Transcatheter Embolization and Occlusion Devices Market
36. Coil Transcatheter Embolization and Occlusion Devices Market Competitive Landscape and Company Profiles
37. Coil Transcatheter Embolization and Occlusion Devices Market Other Major and Innovative Companies
40. Coil Transcatheter Embolization and Occlusion Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Coil Transcatheter Embolization And Occlusion Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses coil transcatheter embolization and occlusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for coil transcatheter embolization and occlusion devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coil transcatheter embolization and occlusion devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Detachable Coils; Pushable Coils; Other Product Types2) By Procedure Type: Hemorrhage Control; Vascular Occlusion; Aneurysm Treatment; Tumor Embolization; Other Procedure Types
3) By Material: Platinum Or Platinum Alloy; Nickel Titanium; Stainless Steel; Other Materials
4) By End-User: Hospitals; Ambulatory Surgical Centers (Ascs); Specialty Clinics; Research And Academic Institutes
Subsegments:
1) By Detachable Coils: Electrically Detachable Coils; Mechanically Detachable Coils2) By Pushable Coils: Fibered Coils; Non-Fibered Coils
3) By Other Product Types: Framing Coils; Filling Coils; Complex-Shaped And Finishing Coils
Companies Mentioned: Johnson and Johnson; Medtronic plc; Stryker Corporation; Boston Scientific Corporation; Terumo Medical Corporation; Cook Medical LLC; Merit Medical Systems Inc.; Penumbra Inc.; MicroVention Inc.; Balt Extrusion SAS; Phenox GmbH; Acandis GmbH & Co. KG; B. Braun Interventional Systems Inc.; EndoShape Inc.; Shape Memory Medical Inc.; Artio Medical Inc.; Kaneka Corporation; Asahi Intecc Co. Ltd.; Medico's Hirata Inc.; Wallaby Medical; Rapid Medical; Stereotaxis Inc.; Imperative Care
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Coil Transcatheter Embolization and Occlusion Devices market report include:- Johnson and Johnson
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- Terumo Medical Corporation
- Cook Medical LLC
- Merit Medical Systems Inc.
- Penumbra Inc.
- MicroVention Inc.
- Balt Extrusion SAS
- Phenox GmbH
- Acandis GmbH & Co. KG
- B. Braun Interventional Systems Inc.
- EndoShape Inc.
- Shape Memory Medical Inc.
- Artio Medical Inc.
- Kaneka Corporation
- Asahi Intecc Co. Ltd.
- Medico's Hirata Inc.
- Wallaby Medical
- Rapid Medical
- Stereotaxis Inc.
- Imperative Care
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.9 Billion |
| Forecasted Market Value ( USD | $ 2.55 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
